A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

Clinical trial NCT00231556 · COMPLETED

Trial details

NCT number: NCT00231556
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy Seizures Epilepsies, Partial Epilepsy, Generalized Epilepsy, Tonic-Clonic

Start date: 1999-07-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.